EU allocates €35M for AI cancer treatment
10 Jul 2019
The European Commission is investing €35 million to develop AI solutions for the treatment and prevention of the most common forms of cancer.
Vytenis Andriukaitis, Commissioner for Health and Food Safety, said: “Working together across silos will boost our capacity to better help the patients by sharing and interpreting technological advances in cancer prevention, diagnosis and treatment prediction across the EU.”
Mariya Gabriel, Commissioner for the Digital Economy and Society, said: “Together with Member States, we must put in place a framework that balances individual concerns and health system constraints, while unleashing innovation in healthcare for the benefit of all Europeans.”
Commissioner Gabriel will on Wednesday convene a roundtable of representatives from the pharmaceutical, biotechnology, and medical technology industries. The roundtable will cover AI, high-performance computing, electronic health records and the digitalisation of health and care, including relevant privacy and data protection.
The funding forms part of Horizon 2020, the EU’s €80 billion research and innovation programme
